Agenus Inc (AGEN) shareholders
Close on Nov 17, 2026Market cap $279.58MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Raymond Debbane Joint filing with Invus Public Equities, L.P. (8.80%), Invus Public Equities Advisors, LLC (8.80%) and 2 more | 4,533,755 | 9.99% | 13G (passive) | Jul 13, 2026 |
| RA Capital Management, L.P. Joint filing with Peter Kolchinsky (9.90%), Rajeev Shah (9.90%) and 1 more | 4,344,772 | 9.90% | 13G (passive) | Jul 13, 2026 |
| BlackRock, Inc. | 2,513,893 | 6.00% | 13G (passive) | Jun 30, 2026 |
| Zydus Lifesciences Ltd Joint filing with Zynext Ventures USA LLC (5.90%), Zynext Ventures Pte Ltd (5.90%) | 2,133,333 | 5.90% | 13D (active) | Jan 15, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AGEN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,564,884 | 5.70% | $7.85M | +2,019,222 | 0.00% |
| Vanguard Capital Management LLC | 1,676,096 | 3.72% | $5.13M | +235,864 | 0.00% |
| Vanguard Portfolio Management LLC | 1,427,587 | 3.17% | $4.37M | +232,478 | 0.00% |
| Siren, L.L.C. | 1,064,250 | 2.36% | $3.26M | – | 0.07% |
| Geode Capital Management, LLC | 1,035,040 | 2.30% | $3.17M | +686,645 | 0.00% |
| Mackenzie Financial Corp | 714,175 | 1.59% | $2.19M | New | 0.00% |
| Goldman Sachs Group Inc | 448,383 | 1.00% | $1.37M | +416,929 | 0.00% |
| Marshall Wace, Llp | 439,621 | 0.98% | $1.35M | −248,582 | 0.00% |
| Raymond James Financial Inc | 430,078 | 0.96% | $1.32M | +190,524 | 0.00% |
| Globeflex Capital L P | 418,581 | 0.93% | $1.28M | New | 0.16% |
| State Street Corp | 412,383 | 0.92% | $1.26M | +256,200 | 0.00% |
| Man Group plc | 340,425 | 0.76% | $1.04M | +61,445 | 0.00% |
| Northern Trust Corp | 314,052 | 0.70% | $961.00K | +224,332 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 310,035 | 0.69% | $948.71K | +111,533 | 0.00% |
| Vanguard Fiduciary Trust Co | 271,614 | 0.60% | $831.14K | +71,116 | 0.00% |
| Morgan Stanley | 262,068 | 0.58% | $801.93K | −33,753 | 0.00% |
| Renaissance Technologies LLC | 228,346 | 0.51% | $698.74K | −57,300 | 0.00% |
| Panagora Asset Management Inc | 179,589 | 0.40% | $549.54K | +16,441 | 0.00% |
| Susquehanna Portfolio Strategies, LLC | 158,737 | 0.35% | $485.74K | New | 0.01% |
| Jump Financial, LLC | 103,981 | 0.23% | $318.18K | −53,219 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 102 | 14M | 31.7% | 31 / 32 | 18 / 15 | 7M | 2M |
| Q1 2026 | 87 | 9M | 20.5% | 13 / 15 | 32 / 20 | 4M | 2M |
| Q4 2025 | 96 | 10M | 22.5% | 22 / 25 | 30 / 10 | 3M | 1M |
| Q3 2025 | 87 | 9M | 19.6% | 21 / 20 | 28 / 24 | 2M | 2M |
| Q2 2025 | 91 | 9M | 19.9% | 33 / 19 | 28 / 29 | 3M | 3M |
| Q1 2025 | 88 | 9M | 19.7% | 18 / 22 | 26 / 14 | 2M | 1M |
| Q4 2024 | 84 | 8M | 18.7% | 17 / 27 | 19 / 30 | 2M | 2M |
| Q3 2024 | 97 | 8M | 18.6% | 32 / 27 | 22 / 21 | 4M | 3M |
| Q2 2024 | 88 | 9M | 19.7% | 84 / 1 | 2 / 5 | 9M | 0M |
| Q1 2024 | 10 | 0M | 0.1% | 10 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
63 funds held AGEN in Q2 2026, 61% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of AGEN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,159,672 | 2.58% | $3.55M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 903,711 | 2.01% | $2.77M | 0.00% | Jun 30, 2026 |
| Vanguard Strategic Equity Fund | 511,809 | 1.14% | $1.57M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 485,158 | 1.08% | $1.48M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 435,952 | 0.97% | $3.27M | 0.01% | Jul 31, 2026 |
| Vanguard Explorer Fund | 290,646 | 0.65% | $2.18M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 258,455 | 0.57% | $790.87K | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 256,842 | 0.57% | $785.94K | 0.01% | Jun 30, 2026 |
| Vanguard Strategic Small-Cap Equity Fund | 205,345 | 0.46% | $628.36K | 0.02% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 163,921 | 0.36% | $573.72K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 133,984 | 0.30% | $409.99K | 0.03% | Jun 30, 2026 |
| Small Company Growth Portfolio | 114,747 | 0.25% | $351.13K | 0.02% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 96,310 | 0.21% | $722.33K | 0.01% | Jul 31, 2026 |
| Siit Small Cap Ii Fund | 84,700 | 0.19% | $296.45K | 0.12% | May 31, 2026 |
| Master Small Cap Index Series | 74,480 | 0.17% | $227.91K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Garo H. Armen | See Remarks, Director | 402,406 | 0.89% | Aug 12, 2026 |
| Jennifer Buell | See Remarks, Director | 19,738 | 0.04% | Aug 7, 2026 |
| Steven J. O'Day | Chief Medical Officer | 57,116 | 0.13% | Aug 7, 2026 |
| Austin Charette | Principal Accounting Officer | 9,115 | 0.02% | Apr 28, 2026 |
| Christine M. Klaskin | PFO & PAO | 23,510 | 0.05% | Jun 30, 2025 |
| Timothy Wright | Director | 55,391 | 0.12% | Oct 2, 2026 |
| Thomas L. Harrison | Director | 51,988 | 0.12% | Oct 2, 2026 |
| Marco Tullio Marcucci | Director | 5,480 | 0.01% | Sep 16, 2026 |
| Brian Corvese | Director | 92,085 | 0.20% | Aug 11, 2026 |
| Susan B. Hirsch | Director | 118,725 | 0.26% | Aug 7, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Thomas L. Harrison Director | Oct 1, 2026 | Award | +4,443 | $6.89 | $30.63K | 51,988 |
| Garo H. Armen See Remarks, Director | Jul 10, 2026 | Award | +4,852 | $3.35 | $16.25K | 371,108 |
| Thomas L. Harrison Director | Jul 1, 2026 | Award | +8,547 | $3.58 | $30.60K | 47,545 |
| Garo H. Armen See Remarks, Director | Jun 26, 2026 | Award | +5,364 | $3.03 | $16.25K | 366,256 |
| Garo H. Armen See Remarks, Director | Jun 12, 2026 | Award | +4,925 | $3.30 | $16.25K | 360,892 |
| Garo H. Armen See Remarks, Director | May 29, 2026 | Award | +4,644 | $3.50 | $16.25K | 355,967 |
| Garo H. Armen See Remarks, Director | May 15, 2026 | Award | +4,540 | $3.58 | $16.25K | 351,323 |
| Garo H. Armen See Remarks, Director | May 1, 2026 | Award | +4,233 | $3.84 | $16.25K | 346,783 |
| Garo H. Armen See Remarks, Director | Apr 17, 2026 | Award | +3,403 | $4.79 | $16.30K | 342,550 |
| Garo H. Armen See Remarks, Director | Apr 3, 2026 | Award | +4,629 | $3.33 | $15.41K | 339,147 |
| Thomas L. Harrison Director | Apr 1, 2026 | Award | +9,228 | $3.32 | $30.64K | 38,998 |
| Garo H. Armen See Remarks, Director | Mar 20, 2026 | Award | +3,983 | $3.71 | $14.78K | 334,518 |
| Garo H. Armen See Remarks, Director | Mar 6, 2026 | Award | +4,994 | $2.96 | $14.78K | 330,535 |
| Garo H. Armen See Remarks, Director | Feb 20, 2026 | Award | +4,829 | $3.06 | $14.78K | 325,541 |
| Garo H. Armen See Remarks, Director | Feb 6, 2026 | Award | +5,027 | $2.94 | $14.78K | 320,712 |
| Garo H. Armen See Remarks, Director | Jan 23, 2026 | Award | +4,562 | $3.24 | $14.78K | 315,685 |
| Garo H. Armen See Remarks, Director | Jan 9, 2026 | Award | +3,780 | $3.91 | $14.78K | 311,123 |
| Thomas L. Harrison Director | Jan 2, 2026 | Award | +7,691 | $3.98 | $30.61K | 29,770 |
| Garo H. Armen See Remarks, Director | Dec 26, 2025 | Award | +4,942 | $3.31 | $16.36K | 307,343 |
| Garo H. Armen See Remarks, Director | Dec 12, 2025 | Award | +4,316 | $3.79 | $16.36K | 302,401 |
| Garo H. Armen See Remarks, Director | Nov 28, 2025 | Award | +3,587 | $4.56 | $16.36K | 298,085 |
| Garo H. Armen See Remarks, Director | Nov 14, 2025 | Award | +3,769 | $4.34 | $16.36K | 294,498 |
| Garo H. Armen See Remarks, Director | Oct 31, 2025 | Award | +4,120 | $3.97 | $16.36K | 290,729 |
| Garo H. Armen See Remarks, Director | Oct 17, 2025 | Award | +4,216 | $3.88 | $16.36K | 286,609 |
| Garo H. Armen See Remarks, Director | Oct 3, 2025 | Award | +3,951 | $4.14 | $16.36K | 282,393 |
| Thomas L. Harrison Director | Oct 1, 2025 | Award | +5,780 | $5.01 | $28.96K | 22,079 |
| Garo H. Armen See Remarks, Director | Sep 19, 2025 | Award | +3,734 | $4.38 | $16.35K | 278,442 |
| Garo H. Armen See Remarks, Director | Sep 5, 2025 | Award | +3,778 | $4.33 | $16.36K | 274,708 |
| Garo H. Armen See Remarks, Director | Aug 22, 2025 | Award | +3,619 | $4.52 | $16.36K | 270,930 |
| Garo H. Armen See Remarks, Director | Aug 8, 2025 | Award | +3,407 | $4.80 | $16.35K | 267,311 |
| Garo H. Armen See Remarks, Director | Jul 25, 2025 | Award | +2,745 | $5.96 | $16.36K | 263,904 |
| Garo H. Armen See Remarks, Director | Jul 11, 2025 | Award | +2,317 | $7.06 | $16.36K | 261,159 |
| Thomas L. Harrison Director | Jul 1, 2025 | Award | +7,401 | $3.46 | $25.61K | 16,299 |
| Garo H. Armen See Remarks, Director | Jun 27, 2025 | Award | +3,436 | $4.76 | $16.36K | 258,842 |
| Steven J. O'Day Chief Medical Officer | Jun 18, 2025 | Award | +43,497 | $4.47 | $194.43K | 57,116 |
| Garo H. Armen See Remarks, Director | Jun 18, 2025 | Award | +61,397 | $4.47 | $274.44K | 255,406 |
| Christine M. Klaskin PFO & PAO | Jun 18, 2025 | Award | +15,782 | $4.47 | $70.55K | 23,478 |
| Garo H. Armen See Remarks, Director | Jun 13, 2025 | Award | +3,480 | $4.70 | $16.36K | 194,009 |
| Garo H. Armen See Remarks, Director | May 30, 2025 | Award | +4,769 | $3.43 | $16.36K | 190,529 |
| Garo H. Armen See Remarks, Director | May 16, 2025 | Award | +4,700 | $3.48 | $16.36K | 185,750 |
| Jennifer Buell Director | May 2, 2025 | Award | +581 | $3.11 | $1.81K | 19,738 |
| Garo H. Armen See Remarks, Director | May 2, 2025 | Award | +5,260 | $3.11 | $16.36K | 181,060 |
| Jennifer Buell Director | Apr 18, 2025 | Award | +869 | $2.08 | $1.81K | 19,157 |
| Garo H. Armen See Remarks, Director | Apr 18, 2025 | Award | +7,886 | $2.08 | $16.40K | 175,800 |
| Jennifer Buell Director | Apr 4, 2025 | Award | +1,159 | $1.56 | $1.81K | 18,288 |
| Garo H. Armen See Remarks, Director | Apr 4, 2025 | Award | +10,288 | $1.56 | $16.05K | 167,914 |
| Thomas L. Harrison Director | Apr 1, 2025 | Award | +8,898 | $2.88 | $25.63K | 8,898 |
| Jennifer Buell Director | Mar 21, 2025 | Award | +1,123 | $1.61 | $1.81K | 17,129 |
| Garo H. Armen See Remarks, Director | Mar 21, 2025 | Award | +9,243 | $1.61 | $14.88K | 157,626 |
| Jennifer Buell Director | Mar 7, 2025 | Award | +409 | $2.35 | $961 | 15,646 |
| Garo H. Armen See Remarks, Director | Mar 7, 2025 | Award | +6,332 | $2.35 | $14.88K | 148,383 |
| Jennifer Buell Director | Feb 21, 2025 | Award | +545 | $3.32 | $1.81K | 15,237 |
| Jennifer Buell Director | Feb 21, 2025 | Award | +626 | $3.32 | $2.08K | 15,318 |
| Garo H. Armen See Remarks, Director | Feb 21, 2025 | Award | +4,483 | $3.32 | $14.88K | 142,051 |
| Jennifer Buell Director | Feb 7, 2025 | Award | +516 | $3.50 | $1.81K | 14,692 |
| Garo H. Armen See Remarks, Director | Feb 7, 2025 | Award | +4,251 | $3.50 | $14.88K | 137,568 |
| Jennifer Buell Director | Jan 24, 2025 | Tax withholding | −270 | $3.57 | $964 | 14,176 |
| Garo H. Armen See Remarks, Director | Jan 24, 2025 | Award | +4,169 | $3.57 | $14.88K | 133,317 |
| Jennifer Buell Director | Jan 24, 2025 | Award | +776 | $3.57 | $2.77K | 14,446 |
| Garo H. Armen See Remarks, Director | Jan 10, 2025 | Award | +4,777 | $3.12 | $14.90K | 129,148 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Agenus's stock actually held short. Settlement fails (shares not delivered on time) peaked at 12,465 shares on Sep 11, 2026 over the last 90 days.
See a number that looks wrong?